Treatment for Constipation in Adults
For an adult with constipation and no significant medical history, start with polyethylene glycol (PEG) 17 grams once daily mixed in 8 ounces of water, and if there is no response after 24-48 hours, add bisacodyl 10-15 mg daily. 1, 2
First-Line Treatment: Polyethylene Glycol (PEG)
PEG is the strongest evidence-based first-line treatment for chronic idiopathic constipation, with a strong recommendation from the 2023 AGA-ACG guidelines. 1
- PEG 17 grams (approximately one heaping tablespoon) should be mixed in 8 ounces of water and taken once daily with food 2, 3
- The dose can be titrated up to twice daily if inadequate response after 48 hours 2, 3
- PEG demonstrates durable response over 6 months and can be used safely long-term without a predetermined stop date 2, 4
- Common side effects include bloating, abdominal discomfort, flatulence, and loose stools, which are generally mild 4
- PEG causes virtually no net electrolyte disturbance, making it safer than magnesium-based alternatives 2
Second-Line Treatment: Add Stimulant Laxatives
If PEG alone is insufficient after 24-48 hours, add a stimulant laxative rather than switching agents 2, 3:
- Bisacodyl 10-15 mg daily is the preferred add-on therapy 2, 3
- Alternatively, senna 15-30 mg at bedtime can be used 3
- Sodium picosulfate also received a strong recommendation in the 2023 guidelines 1
- The goal is to achieve one non-forced bowel movement every 1-2 days 2, 3
Alternative Osmotic Laxatives (If PEG Not Tolerated)
- Magnesium oxide 400-800 mg daily, which can be increased to 1,000-1,500 mg daily as needed 3
- Lactulose 15-30 mL once daily, which can be increased to 30-60 mL two to four times daily 3
Conditional Recommendations: Fiber Supplementation
The 2023 AGA-ACG guidelines gave only a conditional recommendation for fiber, with much weaker evidence than PEG 1:
- Only psyllium has demonstrated effectiveness among fiber supplements 4
- Fiber is most appropriate for patients with documented low baseline dietary fiber intake 4
- Fiber intake should be increased slowly over several weeks to minimize bloating and gas 5
- Bulk laxatives are NOT recommended for opioid-induced constipation and may worsen symptoms in non-ambulatory patients with low fluid intake 1, 2
What NOT to Use
Docusate (stool softeners) should be avoided entirely - multiple guidelines explicitly state it lacks efficacy evidence and is not recommended 2, 4:
- The NCCN guidelines state docusate has not shown benefit 2
- ESMO guidelines list docusate under "laxatives generally not recommended" 2
- Relying on docusate alone without addressing bowel motility is insufficient 2
Rectal Interventions for Severe Cases
If oral therapy fails or if digital rectal exam identifies fecal impaction 1, 2:
- Bisacodyl suppository 10 mg or glycerin suppository as first-line 2, 3
- Small-volume enema (Fleet, saline, or tap water) if suppositories fail 2
- Contraindications: Avoid rectal interventions in neutropenic or thrombocytopenic patients due to infection and bleeding risk 1, 2
Third-Line: Prescription Secretagogues and Prokinetics
For refractory constipation not responding to first and second-line therapies 1:
- Linaclotide 145 mcg once daily (strong recommendation) 1, 6
- Plecanatide (strong recommendation) 1
- Prucalopride 2 mg once daily (strong recommendation, serotonin-4 agonist) 1, 3
- Lubiprostone 24 mcg twice daily (conditional recommendation) 1, 7
Supportive Lifestyle Modifications
While starting pharmacological therapy, recommend 2, 3:
- Increased fluid intake, particularly when using osmotic laxatives 4, 3
- Physical activity when feasible 2, 3
- Adequate dietary fiber from food sources 3
- Scheduled toileting attempts, ideally 30 minutes after meals 1
Treatment Algorithm Summary
- Start immediately: PEG 17g once daily 2, 4, 3
- If no response in 24-48 hours: Add bisacodyl 10-15 mg daily 2, 3
- If still inadequate after 4 weeks: Consider prescription secretagogues (linaclotide, plecanatide, prucalopride) 1, 3
- For impaction: Use rectal interventions (suppositories or enemas) 2
- Reassess every 3-6 months: Evaluate for underlying causes, check electrolytes if using magnesium products, and assess continued need for therapy 2
Critical Pitfalls to Avoid
- Do not prescribe docusate alone - it lacks efficacy and wastes time 2, 4
- Do not use magnesium-based laxatives in renal impairment without monitoring for hypermagnesemia 1, 2, 4
- Do not use bulk laxatives without adequate fluid intake - this can worsen constipation 2
- Do not perform rectal interventions in neutropenic or thrombocytopenic patients 1, 2
- Do not delay treatment waiting for lifestyle modifications alone - pharmacological therapy should begin promptly 1